Biomar Microbial Technologies

Biomar Microbial Technologies is a long-established, privately-held Spanish biotech with a core focus on marine microbiome discovery and microbial fermentation. The company has built a significant asset in the form of a unique, extensively dereplicated collection of marine microorganisms, resulting from over 170 global bioprospecting campaigns conducted over more than 20 years. Its business model combines a service-oriented platform (offering screening, taxonomy, and compound identification) with a product offering of microbial extracts and purified compounds, and a CDMO service for fermentation process development and production. Recognized as an 'Innovative SME' by the Spanish government, Biomar aims to bridge marine biodiversity with industrial and therapeutic R&D.

Marine microbial bioprospecting platform featuring a proprietary collection of >80,000 dereplicated marine-derived microbial strains (Actinomycetes, Fungi, Cyanobacteria). Integrated capabilities in fermentation process development (up to 3,000L GMP), bioactivity screening, and natural product chemistry to generate libraries of extracts and purified compounds with a high rate (24%) of novel chemical structures.

Biomar competes with other microbial strain collection holders and natural product discovery companies, such as Fundación MEDINA (Spain, terrestrial focus) and NAICONS (Italy). It also competes in the microbial fermentation CDMO space with larger, more generalized CDMOs. Its primary differentiation is its specialized, marine-focused strain collection and integrated platform from discovery to mid-scale GMP production.